^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Triapine (3-AP)

    i
    Company:
    Northwestern University, Vion
    Drug class:
    Ribonucleotide reductase inhibitor
    Related drugs:
    Apply
    Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors (ETCTN 10388) (NCT04234568)
    Phase 1
    National Cancer Institute (NCI)
    Active, not recruiting
    Last update posted :
    06/13/2024
    Initiation :
    07/20/2020
    Primary completion :
    12/01/2024
    Completion :
    12/01/2024
    SSTR
    |
    SSTR Expression
    |
    Lutathera (lutetium Lu 177 dotatate) • Triapine (3-AP)